A Revisited Diagnosis of Collagen VI Related Muscular Dystrophy in a Patient with a Novel COL6A2 Variant and 21q22.3 Deletion

Abstract

The genetic etiology of collagen VI related muscular dystrophies is heterogenous. Genomic deletions in one allele involving COL6A2 or both COL6A1 and COL6A2 unmasking a pathogenic variant in the second nondeleted allele have been described in the etiology. We aimed to report the clinical and molecular findings of a 13-year-old boy with ring chromosome 21 who presented to our clinic with easy fatigability, muscle weakness, and waddling gait. Phenotypic delineation along with chromosomal microarray analysis and DNA sequencing were performed. Affymetrix CytoScan Optima array platform and DNA sequencing revealed a 2,202 kb de novo deletion at 21q22.3, including COL6A1 and COL6A2, and a novel heterozygous variant at position c.2875G > A;p.(Glu959Lys) in COL6A2, respectively. Before his admission to our center, the patient was evaluated for hypotonia elsewhere when he was 15 months old. He was diagnosed with ring chromosome 21 on peripheral blood karyotype analysis; however, no further assessment was performed at that time. He had normal growth with mild dysmorphic facial features, distal laxity, gastrocnemius hypertrophy, proximal muscle weakness, increased lordotic posture with mild flexion contractures at the knees, and gait disturbance. Although the phenotype does not fit into classical Ullrich congenital muscular dystrophies, muscle magnetic resonance imaging (MRI) revealed a complementary pattern consistent with collagen VI related myopathies. Genetic testing confirmed the clinical diagnosis as well. This patient yet represents another example of the effect of large genomic deletions leading to recessive disorders through unmasking a pathogenic variant in the second nondeleted allele.

Keywords

Collagen VI related muscular dystrophy - COL6A1 - COL6A2 - 21q22.3 deletion

Publication History

Received: 05 December 2019

Accepted: 26 May 2020

Article published online:
14 July 2020

• References

• 1 Lampe AK, Flanigan KM, Bushby KM, Hicks D. Collagen type VI-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A. eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019
• 2 Foley AR, Hu Y, Zou Y. et al. Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. Ann Neurol 2011; 69 (01) 206-211
• 3 Arslan M, Yiş U, Vurucu S, Tunca Y, Unay B, Akin R. Ring chromosome 21 in the differential diagnosis of waddling gait. Brain Dev 2012; 34 (09) 792-795
• 4 Baker NL, Mörgelin M, Peat R. et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005; 14 (02) 279-293
• 5 Petrini S, Tessa A, Stallcup WB. et al. Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency. Mol Cell Neurosci 2005; 30 (03) 408-417
• 6 Zhang RZ, Zou Y, Pan TC. et al. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant. J Biol Chem 2010; 285 (13) 10005-10015
• 7 Nallamilli BRR, Chakravorty S, Kesari A. et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol 2018; 5 (12) 1574-1587
• 8 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 9 Pepe G, Lucarini L, Zhang RZ. et al. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. Ann Neurol 2006; 59 (01) 190-195
• 10 Lampe AK, Dunn DM, von Niederhausern AC. et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet 2005; 42 (02) 108-120
• 11 Lucioli S, Giusti B, Mercuri E. et al. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology 2005; 64 (11) 1931-1937
• 12 Vanegas OC, Zhang RZ, Sabatelli P. et al. Novel COL6A1 splicing mutation in a family affected by mild Bethlem myopathy. Muscle Nerve 2002; 25 (04) 513-519
• 13 Lejeune J. The 21 trisomy-current stage of chromosomal research. Prog Med Genet 1964; 23: 144-177
• 14 Ferrante E, Vignetti P, Antonelli M, Bruni L, Bertasi S, Chessa L. Partial monosomy for a 21 chromosome. Report of a new case of r(21) and review of the literature. Helv Paediatr Acta 1983; 38 (01) 73-80
• 15 Rope AF, Hinton RB, Spicer RL, Blough-Pfau R, Saal HM. Dilated ascending aorta in a child with ring chromosome 21 syndrome. Am J Med Genet A 2004; 130A [phone]